Cruzeiro do Sul Educacional (CSED3) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
19 Aug, 2026Executive summary
Net revenue rose 8.2% year-over-year in 2Q26 to R$780.3 million, driven by growth in health-related and hybrid courses, with strong re-enrollment and average ticket growth in both On-Campus and Digital segments.
Adjusted EBITDA increased 16.0% to R$233.5 million, with margin expanding 2.0 p.p. to 29.9%, reflecting operational leverage and lower provisions for doubtful accounts.
Net income surged 61% to R$101 million, with margin up 4.2 p.p. to 12.9%, supported by improved financial results and disciplined cost management.
Digital transformation initiatives improved operational efficiency, student engagement, and enrollment conversion.
Student base totaled 554,000, with 173,000 on-campus and 381,000 in digital/hybrid formats.
Financial highlights
Gross profit increased 10% YoY to R$402 million, with gross margin expanding by 0.8 p.p. to 51.5%.
Free cash flow in 2Q26 was R$74.3 million, with free cash flow to equity of R$31.1 million.
Net debt (ex-IFRS 16) was R$523 million, down 22% YoY, with leverage at 0.8x adjusted EBITDA.
Cash costs and expenses fell to 71.2% of net revenue in 2Q26, a 2.0 p.p. efficiency gain YoY.
Capex decreased 17.2% YoY to R$22.3 million in 2Q26.
Outlook and guidance
Strategic expansion in healthcare education, with medical school seats increasing 25% YoY to 1,275 after regulatory approvals.
Continued focus on digital transformation and operational efficiency to drive future growth.
Company monitoring impacts of tax reform and regulatory changes in digital education.
Latest events from Cruzeiro do Sul Educacional
- Revenue and net income surged, driven by student growth, digital gains, and FAPI acquisition.CSED3
Q2 2024 - Record free cash flow and net earnings in 3Q24, with strong growth in students and margins.CSED3
Q3 2024 - Record earnings, robust cash flow, and 12% student growth drove strong 2024 results.CSED3
Q4 2024 - Record earnings, margin expansion, and robust cash flow driven by student and health segment growth.CSED3
Q1 2025 - Net revenue and earnings surged, student base grew 13.9%, and leverage improved to 1.1x.CSED3
Q2 2025 - Net income up 82% in 3Q25, with strong digital and health growth and lower leverage.CSED3
Q3 2025 - Record net profit, margin expansion, and robust cash flow highlight strong 2025 performance.CSED3
Q4 2025 - Revenue up 4.5% year-over-year, but net profit down 28.1% amid higher costs and provisions.CSED3
Q1 2026